58 related articles for article (PubMed ID: 9105083)
21. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
22. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
Voelkel NF; Tuder RM; Wade K; Höper M; Lepley RA; Goulet JL; Koller BH; Fitzpatrick F
J Clin Invest; 1996 Jun; 97(11):2491-8. PubMed ID: 8647941
[TBL] [Abstract][Full Text] [Related]
24. Alveolar hypoxia increases gene expression of extracellular matrix proteins and platelet-derived growth factor-B in lung parenchyma.
Berg JT; Breen EC; Fu Z; Mathieu-Costello O; West JB
Am J Respir Crit Care Med; 1998 Dec; 158(6):1920-8. PubMed ID: 9847287
[TBL] [Abstract][Full Text] [Related]
25. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension.
Christou H; Yoshida A; Arthur V; Morita T; Kourembanas S
Am J Respir Cell Mol Biol; 1998 Jun; 18(6):768-76. PubMed ID: 9618381
[TBL] [Abstract][Full Text] [Related]
26. [Collagen expression of intra-acinar pulmonary arteries and right ventricle and intervention of Radix Astragali in rats with hypoxic pulmonary hypertension].
He J; Jing Z; Gu Q
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):654-6. PubMed ID: 11715451
[TBL] [Abstract][Full Text] [Related]
27. [Effect of 764-3 and ligustrazine on collagen content of extrapulmonary arteries during chronic hypoxia].
Yan Y; Chen X; Sun R
Zhonghua Jie He He Hu Xi Za Zhi; 1996 Aug; 19(4):206-8. PubMed ID: 9596824
[TBL] [Abstract][Full Text] [Related]
28. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
29. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats.
Kouyoumdjian C; Adnot S; Levame M; Eddahibi S; Bousbaa H; Raffestin B
J Clin Invest; 1994 Aug; 94(2):578-84. PubMed ID: 8040313
[TBL] [Abstract][Full Text] [Related]
30. Role of collagen metabolism changes in the pathogenesis of pulmonary hypertension in rats and its reversibility.
Sun R; Yan Y; Chen X; Si Q; Li H
Chin Med Sci J; 1994 Sep; 9(3):183-6. PubMed ID: 7865841
[TBL] [Abstract][Full Text] [Related]
31. Amiloride analogs inhibit chronic hypoxic pulmonary hypertension.
Quinn DA; Du HK; Thompson BT; Hales CA
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1263-8. PubMed ID: 9563749
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.
van Suylen RJ; Smits JF; Daemen MJ
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1423-8. PubMed ID: 9603118
[TBL] [Abstract][Full Text] [Related]
33. Increased lung uptake of liposomes coated with polysaccharides.
Takada M; Yuzuriha T; Katayama K; Iwamoto K; Sunamoto J
Biochim Biophys Acta; 1984 Nov; 802(2):237-44. PubMed ID: 6498216
[TBL] [Abstract][Full Text] [Related]
34. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
[TBL] [Abstract][Full Text] [Related]
35. Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.
Zhu R; Bi LQ; Wu SL; Li L; Kong H; Xie WP; Wang H; Meng ZL
Mol Med Rep; 2015 Aug; 12(2):2945-52. PubMed ID: 25936382
[TBL] [Abstract][Full Text] [Related]
36. Polymer vesicles in vivo: correlations with PEG molecular weight.
Photos PJ; Bacakova L; Discher B; Bates FS; Discher DE
J Control Release; 2003 Jul; 90(3):323-34. PubMed ID: 12880699
[TBL] [Abstract][Full Text] [Related]
37. Bortezomib alleviates experimental pulmonary arterial hypertension.
Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
Voelkel NF; Tuder RM; Bridges J; Arend WP
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):664-75. PubMed ID: 7946395
[TBL] [Abstract][Full Text] [Related]
39. Effect of proline analogs on oxygen toxicity-induced pulmonary fibrosis in the rat.
Riley DJ; Kerr JS; Yu SY
Toxicol Appl Pharmacol; 1984 Sep; 75(3):554-60. PubMed ID: 6474482
[TBL] [Abstract][Full Text] [Related]
40. Treatment of experimental silicosis with antifibrotic agents.
Geismar LS; Kerr JS; Trelstad RL; Riley DJ
Toxicology; 1988 Dec; 53(2-3):331-44. PubMed ID: 3212791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
